Seguridad y beneficios del uso del sevoflurano tópico en el tratamiento de úlceras venosas crónicas: Revisión Bibliográfica
PDF (Español (España))

Keywords

sevofluorane ; varicose ulcer; safety

How to Cite

1.
Fernández Navarro C. Seguridad y beneficios del uso del sevoflurano tópico en el tratamiento de úlceras venosas crónicas: Revisión Bibliográfica. Rev. enferm. vasc. [Internet]. 2023Jul.15 [cited 2024May11];5(8):23-7. Available from: https://revistaevascular.es/index.php/revistaenfermeriavascular/article/view/134

Abstract

Most Chronic venous ulcers cause pain, having a great negative impact on the person's quality of life. In recent years, topical sevoflurane has been used to treat Chronic venous ulcers, although its use has not yet been standard-ized. The aim of this review study was to synthesize and analyze the available scientific evidence on the safety and benefits of topical use of sevoflurane in chronic venous ulcers.
A bibliographic review of the scientific literature available in the main national and international databases with no date limit, in Spanish and English, has been carried out. 134 references were obtained, of which the articles that did not meet the inclusion criteria were eliminated, finally leaving 18 for their qualitative synthesis. Since sevoflurane was administered topically for the first time in 2011, numerous studies have been published demonstrating its benefits in the treatment of chronic venous ulcers, but also the safety of its use, both for the patient and for the healthcare pro-fessional. However, there are still big questions to be answered, such as the dose, frequency of use, therapeutic mar-gins or the wounds that obtain a greater benefit from the topical use of sevoflurane.

https://doi.org/10.35999/rdev.v5i8.134
PDF (Español (España))

References

Aranke M, Pham CT, Yilmaz M, Wang JK, OrhurhuV, An D, Cornett EM, Kaye AD, Ngo AL, Imani F, Farahmand Rad R, Varrassi G, Viswanath O, Urits I.Topical Sevoflurane: A Novel Treatment for Chronic Pain Caused by Venous Stasis Ulcers. Anesth Pain Med. [internet]. 2021. [Citado 2023Abril 15]; 11(1). doi: 10.5812/aapm.112832

Brioni JD, Varughese S, Ahmed R, Bein B. A clinical review of inhalation anesthesia with sevoflurane: from early research to emerging topics. J Anesth.[Internet]. 2017. [Citado 2023 abril 14]; 31(5):726-778. doi: https://doi.org/10.1007/s00540-017-2375-6

Fernández-Ginés D, Cortiñas-Saenz M, Agudo-Ponce D, et al. Pain management & opioid dose reduction with topical sevoflurane instillations in intractable venous ulcers: a case report. Braz. J. Pharm. Sci. 2022; 58. doi: 10.1590/s2175-97902020000318681. Disponible en:https://www.scielo.br/j/bjps/a/mG58BmFXkfwcp4gGNXv9kYf/?format=pdf&lang=en

Fernández-Ginés D, Gerónimo-Pardo M, Cortiñas-Sáenz M. Sevoflurano tópico: una experiencia galena. Farm Hosp. [Internet]. 2021. [citado 2023abril 14]; 45(5):227-81. Disponible en:https://scielo.isciii.es/pdf/fh/v45n5/1130-6343-fh-45-05-277.pdf

Fernández-Ginés D, Cortiñas M, Fernández C, Morales-Molina JA. Sevoflurano tópico: una nueva opción terapéutica paliativa en las úlceras cutáneas. Elsevier. [Internet]. 2017. [Citado 2023 Abril15]; 24(2):104-108. Disponible en:https://www.elsevier.es/es-revista-medicina-paliativa-337-articulo-sevoflurano-topico-una-nueva-opcion-S1134248X15000464

Fernández-Ginés D, Cortiñas-Sáenz M, Mateo-Carrasco H, de Aranda AN, Navarro-Muñoz E,Rodríguez-Carmona R, Fernández-Sánchez C, Sie-rra-García F, Morales-Molina JA. Efficacy and safe-ty of topical sevoflurane in the treatment of chronic skin ulcers. Am J Health Syst Pharm. [In-ternet]. 2017. [citado 2023 Abr 15]; 74(9):176-182. doi: 10.2146/ajhp15100

Fernández-Ginés D, Selva-Sevilla C, Cortiñas-Sáenz M, Gerónimo-Pardo M. Occupational exposure to sevoflurane following topical application to painful wounds. Med Lav. [Internet]. 2019. [Citado2023 Abr 15];110 (5):363-371. doi: 10.23749%2Fmdl.v110i5.836

García JF. Utilización del Sevoflurano de forma tópica en úlceras de extremidad inferior: revisión sistemática. Gerokomos. [Internet]. 2020. [Citado2023 Abril 15]: 31(2). Disponible en:https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1134-928X2020000200011

Gerónimo-Pardo M, Cortiñas-Sáenz M. Eficacia analgésica del sevoflurano tópico en heridas. Rev. Soc. Esp. Dolor [Internet]. 2018. [citado 2023 Abr15]; 25(2): 106-111. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1134-80462018000200106&lng=es

Gerónimo-Pardo M, Martínez-Monsalve A, Martinez-Serrano M. Analgesic effect of topical sevoflurane on venous leg ulcer with intractable pain. Phebologie. [Internet]. 2011. [Citado 2024 Abril15]; 40:95-7. Disponible en:https://anestesiar.org/WP/uploads/2012/02/Ger%C3%B3nimo-2011-Phlebologie-Analgesic-effect-of-topical-sevoflurane-on-venous-leg-ulcer-with-intractable-pain.pdf

Gohel MS, Taylor M, Earnshaw JJ, Heather BP,Poskitt KR, Whyman MR. Risk factors for delayed healing and recurrence of chronic venous leg ulcers an analysis of 1324 legs. Eur J Vasc Endovasc Surg. [Internet] 2005. [Citado 2023 Abril 8]; 29(1):74-7. DOI:10.1016/j.ejvs.2004.10.002

Guardino Solá X, Rosell Farrás MG. NTP 606: Exposición laboral a gases anestésicos. Centro Nacional de Condiciones de Trabajo. Barcelona: Instituto Nacional de Seguridad e Higiene en el Trabajo. Ministerio de Trabajo y Asuntos Sociales. [Inter-net]. 2001. [citado 2023 Abr 15]. Disponible en:https://www.insst.es/documents/94886/326775/ntp_606.pdf/2c8f0378-0e37-48b0-a2a1-5ce1e608638c

Hiller KN, Altamirano AV, Cai C, Tran SF, WilliamsGW. Evaluation of Waste Anesthetic Gas in the Postanesthesia Care Unit within the Patient Breathing Zone. Anesthesiol Res Pract. [Internet].2015. [Citado 2023 Abr 15]; 2015:354184. doi:https://doi.org/10.1155/2015/354184

Imbernon-Moya A, Ortiz-de Frutos FJ, Sanjuan-Álvarez M, Portero-Sánchez I, Merinero-Paloma-res R, Alcázar V. Healing of chronic venous ulcer with topical sevoflurane. Int Wound J. [Internet].2017. [citado 2023 Abr 15];14(6):1323-1326.https://doi.org/10.1111/iwj.12806

Imbernon-Moya A, Ortiz-de Frutos FJ, Sanjuan-Álvarez M, Portero-Sánchez I, Merinero-Palomares R, Alcázar V. Pain and analgesic drugsin chronic venous ulcers with topical sevofluraneuse. J Vasc Surg. [Internet]. 2018. [Citado 2023abril 14]; 68(3):830-835. doi: 10.1016/j.jvs.2017.11.071

Imbernon-Moya A, Ortiz-de Frutos FJ, Sanjuan-Álvarez M, Portero-Sánchez I, Merinero-Paloma-res R, Alcázar V. Pain, Quality of Life, and Functional Capacity With Topical Sevoflurane Application for Chronic Venous Ulcers: A Retrospective Clinical Study. EJVES Short Rep. [Internet].2017.[citado 2023 Abr 15]; 36:9-12. doi:10.1016/j.ejvssr.2017. 08.001

Imbernón Moya A, Ortiz de Frutos FJ, Anjuan Álvarez M, et al. Topical sevoflurane for chronic venousulcers infected by multidrug-resistant organisms.Int Wound J. [Internet]. 2017. [citado 2023 Abr15]: 14, (6): 1388–90. doi: https://doi.org/10.1111%2Fiwj.12794

Instituto nacional de gestión sanitaria. Manual de úlceras crónicas en MMII. Ministerio de sanidad, consumo y bienestar social. [Internet] 2019. [Citado 2023 abril 8] Disponible en: https://ingesa.sanidad.gob.es/bibliotecaPublicaciones/publicaciones/internet/docs/Manual_Ulceras_Cronicas.pdf

Martínez Alfonso F, López Ferreruela I, Peña Miranda C, Villalba Cubero L. Sevoflurano tópico como uso en el tratamiento de úlceras cutáneas crónicas. Ocronos. [Internet]. 2022. [citado 2023Abr 15] : 5, (6):73. Disponible en: https://revistamedica.com/sevoflurano-topico-ulceras-cutaneas/amp/

Nemeth KA, Harrison MB, Graham ID, Burke S. Pain in pure and mixed aetiology venous leg ulcers: a three phase point prevalence study. J Wound Care. [Internet]. 2003.[Citado 2023 abril 8]; 12(9): 336-40.DOI:10.12968/jowc.2003.12.9.265

Phillips TJ, Machado F, Trout R, Porter J, Olin J, Falanga V. Prognostic indicators in venous ulcers. JAm Acad Dermatol. [Internet]. 2000. [Citado 2023abril 8]; 43(4):627-30. doi: 10.1067/mjd.2000.107496

Pinar Sánchez J, Gerónimo-Pardo M. Sevoflurano tópico como terapia de rescate para paciente frágil afecta de úlcera crónica en pierna con dolor refractario y sobreinfectada por Staphylococus aureus resistente a meticilina y Pseudomona aeruginosa sensible. Caso clínico. Secpal. [Internet].2020. [citado 2023 Abr 15]: 27 (2):141-145. doi:10.20986/medpal.2020.1130/2019. Disponible en:https://dialnet.unirioja.es/servlet/articulo?codigo=7534602

Selva-Sevilla C, Fernández-Ginés FD, Cortiñas-Sáenz M, Gerónimo-Pardo M. Cost-effectiveness analysis of domiciliary topical sevoflurane for painful leg ulcers. PLoS One. [Internet]. 2021. [ci-tado 2023 Abr 15]; 16(9):e0257494. doi: 10.1371/journal.pone.0257494

Tankó B, Molnár L, Fülesdi B, Molnár C. Occupa-tional Hazards of Halogenated Volatile Anesthetics and their Prevention: Review of the Literature J Anesth Clin Res. [Internet]. 2014. [Citado 2023Abril 15]. 5 (7). doi: 10.4172/2155-6148.1000426.Disponible en: https://www.longdom.org/open-access-pdfs/occupational-hazards-of-halogenated-volatile-anesthetics-and-their-prevention-review-of-the-literatureevaluation-of-human-factors-in-airway-management-course-2155-6148.1000426.pdf

Torra I, Bou J, Soldevilla JJ, Rueda J, Verdú J, RocheE, Arboix M. Primer Estudio Nacional de Prevalencia de Úlceras de Pierna en España. Estudio GNE-AUPP-UICF-Smith & Nephew 2002-2003. Epidemiología de las úlceras venosas, arteriales, mixtas y de pie diabético. Gerokomos. [Internet]. 2004. [Citado 2023 Abril 8]; 15(4):230-47. Disponible en: https://pesquisa.bvsalud.org/portal/resource/pt/ibc-36412

Valencia IC, Falabella A, Kirsner RS, Eaglstein WH.Chronic venous insufficiency and venous leg ulceration. J Am Acad Dermatol. [Internet]. 2001. [Citado 2023 abril 8]; 44(3):401-21. DOI:10.1067/mjd.2001.111633

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Downloads

Download data is not yet available.